BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-8 out of 8 found
  Current Search:  valproate: 8, sodium: 557     

HTML
63%
Valproate in children with newly diagnosed idiopathic generalized epilepsy
Holland KD et al.

Of 84 patients identified, 48 (57%) became seizurefree on valproate monotherapy and another 10 patients became seizurefree but discontinued VPA because of adverse effects.

The mean dose in seizurefree children was 15.

Valproate in...

MDLinx:  Jan 11 2010 9:29AM
Matching: valproate
Find similar documents
HTML
63%
Lithium Plus Valproate More Likely Than Valproate Alone to Prevent Relapse In Bipolar Disorder
_ Lithium Plus Valproate More Likely Than Valproate Alone to Prevent Relapse In Bipolar Disorder.
Abstracts in Hematology and Oncology:  Jan 6 2010 10:56PM
Matching: valproate
Find similar documents
HTML
63%
Lithium Plus Valproate More Likely Than Valproate Alone to Prevent Relapse In Bipolar Disorder
_ Lithium Plus Valproate More Likely Than Valproate Alone to Prevent Relapse In Bipolar Disorder.
General Medicine eJournal:  Jan 6 2010 10:30PM
Matching: valproate
Find similar documents
HTML
63%
Lithium Plus Valproate More Likely Than Valproate Alone to Prevent Relapse In Bipolar Disorder
_ Lithium Plus Valproate More Likely Than Valproate Alone to Prevent Relapse In Bipolar Disorder.
Medscape:  Jan 6 2010 10:10PM
Matching: valproate
Find similar documents
HTML
100%
Valproate Sodium and related products (valproic acid and divalproex sodium): Increased risk of neural tube def
ROCKVILLE, Md., Dec.

3, 2009-The FDA notified health care professionals and patients about the increased risk of neural tube defects and other major birth defects, such as craniofacial defects and cardiovascular malformations, in babies exposed to valproate ...

Pharma Live:  Dec 4 2009 3:46PM
Matching: valproate sodium
Find similar documents
HTML
100%
Information for Healthcare Professionals: Risk of Neural Tube Birth Defects following prenatal exposure to Val
: The FDA is reminding health care professionals about the increased risk of neural tube defects and other major birth defects, such as craniofacial defects and cardiovascular malformations, in babies exposed to valproate sodiumand related products (valproic...
Pharma Live:  Dec 4 2009 3:44PM
Matching: valproate sodium
Find similar documents
HTML
63%
Pfizer Receives FDA Approval For Geodon (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of
Data Show Geodon Used as an Adjunct to Lithium or Valproate Is Effective in the Maintenance Treatment of Bipolar I Disorder NEW YORK--(BUSINESS WIRE)--Nov 20, 2009 - Pfizer today announced that the U.S.

Food and Drug Administration (FDA) has approved...

Pharma Live:  Nov 20 2009 10:13PM
Matching: valproate
Find similar documents
HTML
63%
Pfizer Receives FDA Approval For Geodon (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment O
Data Show Geodon Used as an Adjunct to Lithium or Valproate Is Effective in the Maintenance Treatment of Bipolar I Disorder NEW YORK--(BUSINESS WIRE)--Pfizer today announced that the U.S.

Food and Drug Administration (FDA) has approved Geodon ...

Business Wire via Yahoo!:  Nov 20 2009 6:21PM
Matching: valproate
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.